We are live on ! Find out more
TARO

Taro Pharmaceutical Industries Ltd.
TARO

Delisted

TARO was delisted on the 21st of June, 2024.

Back to rankings

6 hedge funds and large institutions have $3.27K invested in Taro Pharmaceutical Industries Ltd. in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% less funds holding

Funds holding: 16 → 6 (-10)

100% less capital invested

Capital invested by funds: $29.2M → $3.27K (-$29.2M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 10

Holders
6
Holders Change
-10
Holders Change %
-62.5%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
KAM
Krensavage Asset Management
New York
-$28M
2
AIIMS
Analyst IMS Investment Management Services
Israel
-$583K
3
RhumbLine Advisers
RhumbLine Advisers
Massachusetts
-$542K
4
GCM
Gladius Capital Management
Illinois
-$32.7K
5
Osaic Holdings
Osaic Holdings
Arizona
-$8.55K

TARO Hedge Fund Activity: Q3 2024 in Review

6 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q3 2024, worth a combined $3.27K — down 100% from $29.2M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of TARO and 0 opened new positions — a net loss of 10 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Krensavage Asset Management, exiting entirely with an estimated $28M sold.

  • 6 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q3 2024, down from 16 in Q2 2024.
  • Funds reported $3.27K of Taro Pharmaceutical Industries Ltd. stock for Q3 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q3 2024 and 10 closed out, a net change of -10 holders.
  • The largest Taro Pharmaceutical Industries Ltd. seller in Q3 2024 was Krensavage Asset Management, an estimated $28M sold.

Based on aggregated 13F filings for Q3 2024.